OABI
Price
$1.78
Change
+$0.07 (+4.09%)
Updated
Jun 13 closing price
Capitalization
217.76M
VIGL
Price
$7.86
Change
-$0.01 (-0.13%)
Updated
Jun 13 closing price
Capitalization
366.84M
59 days until earnings call
Interact to see
Advertisement

OABI vs VIGL

Header iconOABI vs VIGL Comparison
Open Charts OABI vs VIGLBanner chart's image
OmniAb
Price$1.78
Change+$0.07 (+4.09%)
Volume$870.39K
Capitalization217.76M
Vigil Neuroscience
Price$7.86
Change-$0.01 (-0.13%)
Volume$3.56M
Capitalization366.84M
OABI vs VIGL Comparison Chart
Loading...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OABI vs. VIGL commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OABI is a Buy and VIGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (OABI: $1.78 vs. VIGL: $7.86)
Brand notoriety: OABI and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OABI: 77% vs. VIGL: 307%
Market capitalization -- OABI: $217.76M vs. VIGL: $366.84M
OABI [@Biotechnology] is valued at $217.76M. VIGL’s [@Biotechnology] market capitalization is $366.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OABI’s FA Score shows that 1 FA rating(s) are green whileVIGL’s FA Score has 0 green FA rating(s).

  • OABI’s FA Score: 1 green, 4 red.
  • VIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both OABI and VIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OABI’s TA Score shows that 3 TA indicator(s) are bullish while VIGL’s TA Score has 4 bullish TA indicator(s).

  • OABI’s TA Score: 3 bullish, 5 bearish.
  • VIGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than OABI.

Price Growth

OABI (@Biotechnology) experienced а +18.67% price change this week, while VIGL (@Biotechnology) price change was -0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

OABI is expected to report earnings on Mar 18, 2025.

VIGL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($367M) has a higher market cap than OABI($218M). VIGL YTD gains are higher at: 362.353 vs. OABI (-49.718). OABI has higher annual earnings (EBITDA): -47.42M vs. VIGL (-91.27M). VIGL has more cash in the bank: 87.1M vs. OABI (43.6M). VIGL has less debt than OABI: VIGL (12.7M) vs OABI (22.5M). OABI has higher revenues than VIGL: OABI (26.7M) vs VIGL (0).
OABIVIGLOABI / VIGL
Capitalization218M367M59%
EBITDA-47.42M-91.27M52%
Gain YTD-49.718362.353-14%
P/E RatioN/AN/A-
Revenue26.7M0-
Total Cash43.6M87.1M50%
Total Debt22.5M12.7M177%
TECHNICAL ANALYSIS
Technical Analysis
OABIVIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
46%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
41%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 13 days ago
87%
Declines
ODDS (%)
Bearish Trend 17 days ago
85%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPOAX41.97-0.37
-0.87%
Morgan Stanley Insight A
PNEAX10.18-0.09
-0.88%
Virtus NFJ Dividend Value A
IVRTX28.12-0.25
-0.88%
VY® CBRE Real Estate S2
CSGIX11.49-0.12
-1.03%
Calamos International Small Cap Gr I
AMIGX81.40-1.01
-1.23%
Amana Growth Institutional

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with MRUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
-0.13%
MRUS - VIGL
49%
Loosely correlated
-1.41%
IMNN - VIGL
47%
Loosely correlated
-11.73%
OABI - VIGL
37%
Loosely correlated
+4.09%
ELVN - VIGL
36%
Loosely correlated
+11.44%
RCKT - VIGL
36%
Loosely correlated
-4.56%
More